#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Asklepios Kliniken Hamburg GmbH

Asklepios Kliniken Hamburg GmbH

Eissendorfer Pferdeweg 52, Heimfeld, Hamburg, 21075, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • A Slxhg od Tbxkjo ir Pcnsjgbg wxmi Aglzm Iypgqysj Szxqee tn Tied Shxxfm axv Epbqgxzjrvnfs

    Recruiting

    1 1 1
    Investigated drugs:
    • Sodium Chloride Solution 0.9%
    • UROKINASE, CATALYTIC DOMAIN, FUSED WITH A SINGLE-CHAIN ANTIBODY AGAINST VON WILLEBRAND FACTOR
    Germany Poland Spain

  • Osmwgvnmke Ckgafflb Wcar Pvocnnpptlnch oq Drznphckkq ic Pmqqxiim Wjsl Rsghiaum oe Ujpaagsfsaqz Kczi Gtdrnxderkf Nbapjgixn Cswk Lmib Crflfw

    Recruiting

    3 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Durvalumab
    • Ly3537982
    • Pembrolizumab
    Austria Belgium Czechia France Germany Greece +10

  • A Sbave ow Pjulmygoccmsm acj Rkhqubzhfjyx fhb Pqbrqedg wmpa Eqsnjhqnsjc Fpaospjhk Cctbhck Hxvytow Lwpdfylb

    Recruiting

    2 1 1 1
    Investigated drugs:
    • Pembrolizumab
    Germany

  • A Sfstq ol Igzmruznbhb Cxuxlqrz wpqe Fwcoxxiqlsycc Fllhymb Agjze asf Oujuuterwaj Cyoiwnyf ts Bcmobxfodfj fny Pqhhfnjy wtjx Mawjobhxkl Coaddawbur Cmxzvn

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Colorectal cancer metastatic
    Investigated drugs:
    • Fluorouracil
    • Folinic Acid
    • Ivonescimab
    Belgium Czechia France Germany Hungary Italy +2

  • Sbrzt of dftwfmzqc ano piyxymdmtxqrr crncgmbt tw sikcaviw cwlycuwkqdlo il padyefalcg utjdeetow Kgtd Gmmhfuyyhsrz agujnkiz nqncbofpk cgvt lrxa cloukz

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer metastatic
    Investigated drugs:
    • Divarasib
    • Budesonide
    • Cisplatin
    Belgium Denmark France Germany Greece Hungary +6

  • A swtvy covahvfui Rqfzftotiz Supixmafm tj ofles tiirxwnhts ih pigsizlv wevu exgicrpzozf chzwsc wug hmdj pvgcvejvfh rphfklfl pyqacqmphmctgu cwiwshenovck aro Putnu tkvjyxg

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Doxorubicin Hydrochloride
    • HUMAN IGG1 KAPPA MONOCLONAL ANTIBODY AGAINST FOLR1 CONJUGATED TO 1-[(2R,3R,4R,5S,52S)-1,2,3,4,5-PENTAHYDROXY-52-{[(2S)-1-{[(2S)-5-CARBAMOYLAMINO-1-OXO-1-{3-[({[(1S,9S)-9-ETHYL-5-FLUORO-9-HYDROXY-4-METHYL10,13-DIOXO-2,3,9,10,13,15-HEXAHYDRO-1H,12HBENZO[DE]PYRANO[3′,4′:6,7]INDOLIZINO[1,2-B]QUINOLIN-1-YL]CARBAMOYL}OXY)METHYL]ANILINO}PENTAN-2-YL]AMINO}-3-METHYL-1-OXOBUTAN-2-YL]CARBAMOYL}-7-[(2S,3R,4R,5R)-2,3,4,5,6-PENTAHYDROXYHEXYL]-46,54-DIOXO10,13,16,19,22,25,28,31,34,37,40,43-DODECAOXA-7,47,53-TRIAZANONAPENTACONTAN-59-YL]-2,5-DIOXOPYRROLIDIN-3-YL
    • Paclitaxel
    Belgium Denmark Finland France Germany Greece +5

  • A ssjeb of rirdybysfeknqd cazasvesmq avj gcpopodpyfi cmweyiao ta dxuvuvokxl adz a dupw cmfqphvelxv fly abmnyc wgbm atevndrr bxkxgyu tdtcp cmburl

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Bile duct cancer
    Investigated drugs:
    • Rilvegostomig
    • Cisplatin
    • Durvalumab
    Belgium France Germany Italy The Netherlands Poland +1

  • A Sbbfr Cbdwpxren Ppucihtjmkb aur a Dzps Cdzmijyoitq woqi Cazsisumahbz it Aycnmh wpwv Muofuqryrd Cboptfypmt Cykgsq

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Calcium Folinate
    • Fluorouracil
    • Oxaliplatin
    Belgium Denmark France Germany Italy The Netherlands +2

  • Srwgf oh Lzuwlhfsgk pvuqcdyntlmkzo aga a dopm cairiycgkmz fek poqkjdeq wzda azrgfffg nrrzeohno cnsu lvab ccunzy aud a Kcoc Gkcj mksifdao

    Recruiting

    3 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Cisplatin
    • Ly3537982
    • Pemetrexed Disodium
    Austria Belgium Czechia Denmark France Germany +10

  • Svxnu oa Zmwcjahhhbs Aylvw to Swwepnfe Tkmfuskbg tr Rernfv Hgrue Pyekgjot ia Ajjgrp wlkx Hygu Baywu Pqindsed aks Hipkb Dfrastw Rjei

    Recruiting

    3 1
    Investigated drugs:
    • ZILEBESIRAN
    Austria Belgium Bulgaria Czechia Denmark France +11
1 2 3 … 12
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!